» Articles » PMID: 35279965

Promotes Cervical Cancer Progression Via Regulating / Axis

Overview
Journal Cell J
Specialty Cell Biology
Date 2022 Mar 13
PMID 35279965
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to investigate the biological function of circular RNA (circRNA) in the cervical cancer (CC).

Materials And Methods: In this experimental study, the GSE113696 dataset was downloaded from the Gene Expression Omnibus (GEO). GEO2R was employed to obtain differentially expressed circRNA between CC tissues and matched paracancerous tissues. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were employed to detect , microRNA-337-3p ( ) and transforming growth factor, beta receptor I () expression levels in the CC tissues and cells. Following gain-of-function and loss-of-function models establishment, CCK-8 and BrdU tests were conducted to examine cell proliferation. Transwell experiment was executed to examine CC cells migration and invasion. A lung metastasis model was utilized to determine the ability of on the lung metastasis. Bioinformatics analysis, dual-luciferase reporter experiment and RNA immunoprecipitation (RIP) assay were applied to verify the targeting relationship among , , and .

Results: expression in the CC tissues and cells was up-modulated. overexpression markedly enhanced cell proliferation, migration, and invasion, while knocking down remarkably repressed cell proliferation, migration, and invasion. could be adsorbed by . was identified as a target gene of that indirectly and positively modulated by in the CC cells.

Conclusion: up-modulates by targeting to enhance CC cell proliferation, migration and invasion. Also, is a promising therapeutic target for the CC.

Citing Articles

circ_0006789 promotes cervical cancer development via the miR-615-5p/HSF1 axis.

Zhou W, Song W, Lu M Discov Oncol. 2024; 15(1):165.

PMID: 38748048 PMC: 11096288. DOI: 10.1007/s12672-024-01012-1.


Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.

Trsova I, Hrustincova A, Krejcik Z, Kundrat D, Holoubek A, Staflova K Mol Oncol. 2023; 17(12):2565-2583.

PMID: 37408496 PMC: 10701770. DOI: 10.1002/1878-0261.13486.

References
1.
Qu S, Zhong Y, Shang R, Zhang X, Song W, Kjems J . The emerging landscape of circular RNA in life processes. RNA Biol. 2016; 14(8):992-999. PMC: 5680710. DOI: 10.1080/15476286.2016.1220473. View

2.
Chen X, Deng Y, Wang Z, Wei W, Zhou C, Zhang Y . Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis. 2019; 10(7):508. PMC: 6602971. DOI: 10.1038/s41419-019-1748-1. View

3.
Chen R, Liu H, Yang L, Kang F, Xin L, Huang L . Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci. 2019; 23(20):8771-8778. DOI: 10.26355/eurrev_201910_19271. View

4.
Zhou B, Guo W, Sun C, Zhang B, Zheng F . Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Cell Death Dis. 2018; 9(6):706. PMC: 5999603. DOI: 10.1038/s41419-018-0724-5. View

5.
Gao P, Wang H, Yu J, Zhang J, Yang Z, Liu M . miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2. PLoS Genet. 2018; 14(12):e1007790. PMC: 6312350. DOI: 10.1371/journal.pgen.1007790. View